U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2020-12, Vol.76 (24), p.2907-2910
Hauptverfasser:	Aggarwal, Rahul, Lu, Kimberly, Chiu, Nicholas, Bakris, George L, Bhatt, Deepak L
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Clinical Trials as Topic Diabetes Complications - drug therapy Female Humans Male Middle Aged Nutrition Surveys Renal Insufficiency, Chronic - drug therapy Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	2910
container_issue	24
container_start_page	2907
container_title	Journal of the American College of Cardiology
container_volume	76
creator	Aggarwal, Rahul Lu, Kimberly Chiu, Nicholas Bakris, George L Bhatt, Deepak L
description
doi_str_mv	10.1016/j.jacc.2020.09.616
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2483409337</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2483409337</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-b2ede93bc3c6f60f5ba75b2273637ab9c66ba7335b167d7433e4703ed1a01bea3</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EgvL4ARbISzYJ40xiN0tUnqISSBSxtPyYqK7apNgpUv-elNdqpDP33sVh7FxALkDIq0W-MM7lBRSQQ51LIffYSFTVOMOqVvtsBAqrTECtjthxSgsAkGNRH7IjRASEsRix9i1_zflLpE-zpNYR7xr-2PrwGfzGLBN_D_2c3wRjqafETev5ZB67Njj-FHxL2-GXyCT6LjnTk-dNF_nr_XSWFQOcBxv6AczmFM16e8oOmmGWzn7vCXu7u51NHrLp8_3j5HqaOSxVn9mCPNVoHTrZSGgqa1Rli0KhRGVs7aQcCGJlhVRelYhUKkDywoCwZPCEXf7srmP3saHU61VIjpZL01K3Sboox1hCjaiGaPETdbFLKVKj1zGsTNxqAXrnWS_0zrPeedZQ68HzULr43d_YFfn_yp9Y_AL9aHl2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2483409337</pqid></control><display><type>article</type><title>U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Aggarwal, Rahul ; Lu, Kimberly ; Chiu, Nicholas ; Bakris, George L ; Bhatt, Deepak L</creator><creatorcontrib>Aggarwal, Rahul ; Lu, Kimberly ; Chiu, Nicholas ; Bakris, George L ; Bhatt, Deepak L</creatorcontrib><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2020.09.616</identifier><identifier>PMID: 33303081</identifier><language>eng</language><publisher>United States</publisher><subject>Aged ; Clinical Trials as Topic ; Diabetes Complications - drug therapy ; Female ; Humans ; Male ; Middle Aged ; Nutrition Surveys ; Renal Insufficiency, Chronic - drug therapy ; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</subject><ispartof>Journal of the American College of Cardiology, 2020-12, Vol.76 (24), p.2907-2910</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-b2ede93bc3c6f60f5ba75b2273637ab9c66ba7335b167d7433e4703ed1a01bea3</citedby><cites>FETCH-LOGICAL-c347t-b2ede93bc3c6f60f5ba75b2273637ab9c66ba7335b167d7433e4703ed1a01bea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33303081$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aggarwal, Rahul</creatorcontrib><creatorcontrib>Lu, Kimberly</creatorcontrib><creatorcontrib>Chiu, Nicholas</creatorcontrib><creatorcontrib>Bakris, George L</creatorcontrib><creatorcontrib>Bhatt, Deepak L</creatorcontrib><title>U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><subject>Aged</subject><subject>Clinical Trials as Topic</subject><subject>Diabetes Complications - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nutrition Surveys</subject><subject>Renal Insufficiency, Chronic - drug therapy</subject><subject>Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMtOwzAQRS0EgvL4ARbISzYJ40xiN0tUnqISSBSxtPyYqK7apNgpUv-elNdqpDP33sVh7FxALkDIq0W-MM7lBRSQQ51LIffYSFTVOMOqVvtsBAqrTECtjthxSgsAkGNRH7IjRASEsRix9i1_zflLpE-zpNYR7xr-2PrwGfzGLBN_D_2c3wRjqafETev5ZB67Njj-FHxL2-GXyCT6LjnTk-dNF_nr_XSWFQOcBxv6AczmFM16e8oOmmGWzn7vCXu7u51NHrLp8_3j5HqaOSxVn9mCPNVoHTrZSGgqa1Rli0KhRGVs7aQcCGJlhVRelYhUKkDywoCwZPCEXf7srmP3saHU61VIjpZL01K3Sboox1hCjaiGaPETdbFLKVKj1zGsTNxqAXrnWS_0zrPeedZQ68HzULr43d_YFfn_yp9Y_AL9aHl2</recordid><startdate>20201215</startdate><enddate>20201215</enddate><creator>Aggarwal, Rahul</creator><creator>Lu, Kimberly</creator><creator>Chiu, Nicholas</creator><creator>Bakris, George L</creator><creator>Bhatt, Deepak L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20201215</creationdate><title>U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy</title><author>Aggarwal, Rahul ; Lu, Kimberly ; Chiu, Nicholas ; Bakris, George L ; Bhatt, Deepak L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-b2ede93bc3c6f60f5ba75b2273637ab9c66ba7335b167d7433e4703ed1a01bea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Clinical Trials as Topic</topic><topic>Diabetes Complications - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nutrition Surveys</topic><topic>Renal Insufficiency, Chronic - drug therapy</topic><topic>Sodium-Glucose Transporter 2 Inhibitors - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aggarwal, Rahul</creatorcontrib><creatorcontrib>Lu, Kimberly</creatorcontrib><creatorcontrib>Chiu, Nicholas</creatorcontrib><creatorcontrib>Bakris, George L</creatorcontrib><creatorcontrib>Bhatt, Deepak L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aggarwal, Rahul</au><au>Lu, Kimberly</au><au>Chiu, Nicholas</au><au>Bakris, George L</au><au>Bhatt, Deepak L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2020-12-15</date><risdate>2020</risdate><volume>76</volume><issue>24</issue><spage>2907</spage><epage>2910</epage><pages>2907-2910</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><cop>United States</cop><pmid>33303081</pmid><doi>10.1016/j.jacc.2020.09.616</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0735-1097
ispartof	Journal of the American College of Cardiology, 2020-12, Vol.76 (24), p.2907-2910
issn	0735-1097 1558-3597
language	eng
recordid	cdi_proquest_miscellaneous_2483409337
source	MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects	Aged Clinical Trials as Topic Diabetes Complications - drug therapy Female Humans Male Middle Aged Nutrition Surveys Renal Insufficiency, Chronic - drug therapy Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
title	U.S. Prevalence of Individuals With Diabetes and Chronic Kidney Disease Indicated for SGLT-2 Inhibitor Therapy
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T06%3A22%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=U.S.%20Prevalence%20of%20Individuals%20With%20Diabetes%20and%20Chronic%20Kidney%20Disease%20Indicated%20for%20SGLT-2%20Inhibitor%20Therapy&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Aggarwal,%20Rahul&rft.date=2020-12-15&rft.volume=76&rft.issue=24&rft.spage=2907&rft.epage=2910&rft.pages=2907-2910&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2020.09.616&rft_dat=%3Cproquest_cross%3E2483409337%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2483409337&rft_id=info:pmid/33303081&rfr_iscdi=true